Connect with us

Emerging Markets

Trans Global Group Inc (OTCMKTS: TGGI) Coiled Tight Over a Penny for Breakout as RM Play Looks to Piggy Back to OTCQB

Published

1 year ago

on

Trans Global Group Inc (OTCMKTS: TGGI) is holding strong above a penny not giving up much in recent weeks as the overall markets have seen significant declines.  There are a lot of things happening behind the scenes at TGGI and while the enormous investor base anxiously awaits an 8k announcing the Zuixiangui RM, TGGI may be granted OTCQB designation from OTCMarkets with TGGI returning to piggy back qualified status with the shell designation removed on OTCMarkets as soon as this week. As we have been reporting on TGGI, the stock has been getting noticed by investors ever since Chen Ren Feiyang became new majority owner of the Company. TGGI has gained legions of international followers and besides the lack of recent news the stock continues to average well over $250,000 in daily dollar volume. 

Reverse merger stocks can be more explosive than biotech’s when the incoming Company has real value but is still undiscovered to investors and we have covered many of them here on Microcapdialy including TSNP, HRBR and many others. TGGI has got a lot of support among investors who are looking for an eclipse of recent $0.028 highs and on to a whole new dimension. Interest on TGGI has picked up after Chinese Entrepeneur Chen Ren Feiyang took control of the Company. Mr. Chen Ren is the founder and owner of Zuixiangui, an important name in the Chinese wine Market producing over 4,000 tons (11M 1 Liter bottles) annually using patented methods of production on an operations site of more than 300 acres. Zuixiangui’s intent to gain access to US capital markets is highlighted in numerous articles, which states that Zuixiangui has already started the listing process and is preparing to go public on the Nasdaq stock exchange. Penny stock speculators are well aware that an 8k could drop on TGGI at any moment announcing the Zuixiangui reverse merger sending TGGI into a whole new stratosphere. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Trans Global Group Inc (OTCMKTS: TGGI) operating out of Guangdong Province, China and registered in Delaware is a holding company that plans to establish subsidiaries in Hong Kong, and/or the Cayman Islands. Such subsidiaries will then acquire assets or shares of an entity actively engaged in business which generates revenues in exchange for its securities. The Company’s major shareholders and headquarters are located in China and it plans to acquire operating assets and businesses in China. On April 29, 2021, ONE DAY after the HK requirements for filings Chen Ren Feiyang executed the Change of Control documents for $TGGI. In it, they stated CLEAR intentions to acquire liquor companies in China. Chen Ren is now the controlling shareholder of TGGI having purchased control for $150,000.  

history of TGGI: Trans Global Group, Inc. was originally incorporated in Colorado on April 2, 1979 as Teletek, Inc. On April 9, 1993, the Company effected a merger with a newly formed wholly-owned subsidiary for the primary purpose of changing its domicile to Delaware. On October 2007, the Company changed its name to Trans Global Group, Inc. The Company reincorporated to Florida from March 2014, through September 2017, and changed its name to Cannabis Consortium, Inc. in September 2017. On September 18, 2017, the Company filed with the State of Delaware to move the Company’s State of domicile from Florida to Delaware. On September 19, 2017, the Company filed conversion documents with the State of Florida moving its domicile to Delaware. In connection with the change in domicile, the Company changed its name from Cannabis Consortium, Inc. back to Trans Global Group, Inc. 

From inception through 1996, the Company was engaged in various facets of the telecommunications industry, including providing long-distance telecommunications services, consisting primarily of direct dial international long-distance telephone transmissions from the United States for commercial customers. In 1996, the Company ceased telecommunications operations. At one point in 2016 famed penny stock promoter/CEO Matthew Dwyer took control of the Company and changed the name to Cannabis Consortium, Inc. and created a line of edible sauces that can be infused with CBD and/or THC in three different original flavors. 

Unlike most penny stock reverse merger plays including some of the biggest RM plays in recent OTC history such as TSNP, TGGI is an SEC filer filing their 10k on March 29, 2022 and their 10Q on May 13 making them eligible for up-listing on the OTCQB market sponsored by OTC Markets. Management correctly believes that being a reporting company under the Securities Exchange Act will enhance efforts to acquire or merge with an operating business. In fact, a fully reporting OTCQB shell is worth almost double what a “pink sheet” shell is worth and a quick look at OTCMarkets shows that out of a total of 1, 275 OTCQB listed securities there are only 5 securities trading for less than a penny; the lowest priced OTCQB security is $0.0075 just under a penny and the higher priced is $112. 

Microcapdaily previously reported on TGGI stating at the time:  

Reverse Merger stocks (RM) are easily among the most exciting and explosive stocks in small caps rivaling only biotech’s in their ability to make historic gains and TGGI has been no exception so far. The ambitious new CEO and controlling shareholder of the Company Chen Ren is the founder and owner of Zuixiangui wines which produces over 4,000 tons (11M 1 Liter bottles) annually using patented methods of production on an operations site of more than 300 acres. It is expected that Zuixiangui wines will reverse merge into TGGI. Chen’s passion for wine matched his dreams of becoming a public company and he has made clear his intentions to one day list TGGI on the big boards.

  To Find out the inside Scoop on TGGI Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

TGGI

Chen Ren Feiyang was a famous singer/entertainer in his earlier years. Amongst his many songs/albums, he made numerous songs about wine. He dreamed of making a specific wine and sharing it with the world. Chen’s passion for wine matched his dreams of becoming a NASDAQ company and he has made clear his intentions to one day list TGGI on the big boards. Mr. Ren is the founder and owner of Zuixiangui wines which produces over 4,000 tons (11M 1 Liter bottles) annually using patented methods of production on an operations site of more than 300 acres. It is expected that Zuixiangui wines will reverse merge into TGGI. Zuixiangui has also been making some big moves recently Shaanxi Seeds and Hunan Pharmaceuticals both established business in China. They also announced an incredibly strategic and exciting contract with Yijulian E-commerce Co. TGGI is authorized to issue 12,000,000,000 shares of common stock with a par value of $0.0001 per share. As of December 31, 2021, 8,665,578,306 shares were issued and outstanding.  

According to a number of recent twitter threads Chen Rens Zuixiangui and Red ant have merged together creating a new conglomerate that can be merged into TGGI. Red Ant APP is a social e-commerce platform for boutique members. Through the direct procurement strategy of the source factory of the world’s selected supply chain. Red ant has a triple A evaluation and is a top ten leading brands of Chinese e-com. Earlier this year Zuixiangui formed a “strategic cooperation” with Chengwei Technology, an enterprise “Born for the meta-verse” whose products are already being sold on the Red Ant App. 

Zuixiangui’s intent to gain access to US capital markets is highlighted in numerous articles, which state that Zuixiangui has already begun the process to up list and is looking to go public on the NASDAQ. Ren Chen is the Chairman of the Board of both Trans Global Group and Zuixiangui International Holdings Group and he is also the controlling shareholder of TGGI.   

Zuixiangui International Holdings Group, a specialty wine and spirits company based in China is making moves in nanotechnology-based wine production. Currently one of the key fields in which nanotechnology is applied is in viticulture and enology, where nanomaterials designed as antimicrobial agents are used. Among these [nano]materials, the use of silver nanoparticles appears to be very attractive/popular in microbial wine control. One example of how this works is through the attachment of magnetic nano particles to a special polymer that is then added to wine to bind with impurities before then being extracted, leaving the impurities behind and resulting in a cleaner, superior wine. 

For More on TGGI Subscribe Right Now!

TGGI is holding strong above a penny not giving up much in recent weeks as the overall markets have seen significant declines.  There are a lot of things happening behind the scenes at TGGI and while the enormous investors base anxiously awaits an 8k announcing the Zuixiangui RM, TGGI may be granted OTCQB designation from OTCMarkets with TGGI returning to piggy back qualified status with the shell designation removed on OTCMarkets as soon as this week. Once OTCQB is achieved and the shell designation is gone, TGGI will be the most attractive RM candidate in penny stocks; even the biggest RM runners such as TSNP were pink sheets, and TGGI is virtually debt free to with just $82,404 in liabilities, $64,404 of which is owed to a director of the Company. We will be updating on TGGI when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with TGGI.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in TGGI either long or short and we have not been compensated for this article

Related Topics:
Continue Reading
1 Comment

1 Comment

  1. Gway0524

    June 5, 2022 at 9:22 am

    https://twitter.com/gway0524/status/1533200815200116736?s=21&t=8cQzH31N_LfcCiTC3q-w5g Check out the translated videos from them showing what exactly what their plans are with this RM.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Lucy Scientific Discovery’s (NASDAQ: LSDI) Game-Changing Move: A Closer Look at the High Times Acquisition

Published

2 weeks ago

on

September 8, 2023

By

On August 8th, 2023, Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a leading developer in the psychedelic drug industry, witnessed an impressive surge in its stock value, gaining approximately 25% in combined trading, including after-hours (AH) trading. The British Columbia-based company made headlines by announcing its strategic move to acquire intellectual property (IP) from the renowned cannabis publication, High Times Holding Corp. (HHC).

Additional Background:

Under this agreement, Lucy will exchange 20% of its shares and a series of payments for access to HHC’s valuable IP portfolio, which includes the rights to generate licensing and royalty income from renowned brands like High Times, 420.com, and Cannabis Cup, along with their associated domain names.

Lucy’s commitment involves making semi-annual payments to HHC over a five-year period, structured around earnings before income, taxes, depreciation, and amortization (EBITDA) generated through the acquired IP. The flexibility exists for Lucy to fulfill these payments either in cash or through stock issuance and the announcement is generating considerable interest.

Furthermore, post-acquisition, Lucy will grant High Times the opportunity to operate retail outlets and distribute THC products bearing these prestigious brands within the United States. This privilege comes in exchange for an annual license fee of $1 million, set to double to $2 million annually once federal legalization of cannabis occurs in the country.

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Leveraging the brand rights secured from HHC, Lucy aims to bolster its revenue streams by expanding and enhancing its existing 18 licensing agreements, both domestically and internationally. These arrangements encompass a wide array of consumer products and merchandise, promising to further establish Lucy’s presence in the global market. The acquisition is expected to be finalized within the coming two weeks, marking a significant strategic move for Lucy Scientific Discovery Inc.

As a result of the acquisition, High Times is now a publicly-traded entity. Lucy anticipates that this agreement will contribute over $10 million in revenue to its financial results in the upcoming year, along with $5 million in EBITDA.

Adam Levin, the Executive Chairman of HHC, expressed optimism about the deal, noting, “This transaction will create exciting new growth opportunities for the High Times brand, under the leadership of Richard Nanula, a seasoned executive with extensive experience in major consumer brands and global corporations.”

Levin also emphasized High Times’ enthusiasm in becoming a significant shareholder of Lucy Scientific Discovery. Notably, Lucy completed its initial public offering and Nasdaq listing in February, offering 1,875,000 shares at $4.00 each.

Richard Nanula, CEO of the British Columbia-based company, shared his outlook on the acquisition, stating, “Lucy expects this acquisition to rapidly generate high-margin revenue within the global cannabis sector.”

In recent developments, Lucy introduced the sleep aid product “Twilight,” which includes amanita muscaria and reishi mushrooms. Additionally, the company joined forces with Wesana Health Holdings Inc. (OTCQB: WSNAF) in March to collaborate on the development of the CBD and psilocybin-based drug SANA-013, targeting conditions such as migraines, cluster headaches, and major depressive disorder.

High Times, founded in 1974, has a rich history, featuring works by renowned writers like Truman Capote and Hunter S. Thompson. Since 1988, its Cannabis Cup has stood as the most prestigious cannabis competition globally, with notable judges including Snoop Dogg, Joe Rogan, Tommy Chong, and other prominent figures in the cannabis industry.

While Lucy’s shares showed a nearly 16% increase to reach $0.68 on the Nasdaq exchange on Friday, it is worth noting that they have experienced a decline of over 77% over the past year.

Macro Trend:

In recent times, our articles have prominently featured cannabis-related topics, reflecting the growing popularity of stocks in this sector. LSDI’s acquisition aligns perfectly with the current climate, as the cannabis industry experiences a significant surge, coinciding with the Health and Human Services (HHS) exploring the possibility of reclassifying cannabis from Schedule I to Schedule III of the Controlled Substances Act.

While many countries around the world have already moved towards decriminalization and legalization, the United States has been relatively cautious in its approach. However, the consideration of such a reclassification represents a potential historic turning point. If such a change were to materialize, it would mark a substantial shift in the regulatory landscape, potentially revitalizing cannabis as an attractive investment opportunity. The industry is already showing signs of reestablishing its market presence and could once again become a noteworthy investment option.

We will update you on LSDI when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by herbalhemp from Pixabay

 

Continue Reading

Emerging Markets

WM Technology’s (NASDAQ: MAPS) Stock Surges 91% in Mysterious Rally: What’s Behind the Boom?

Published

3 weeks ago

on

September 5, 2023

By

WM Technology’s (NASDAQ: MAPS) stock has exhibited remarkable growth, surging by an impressive 91% since August 16th, 2023. Intriguingly, this surge occurred in the absence of any substantial news or filings from the company, with their most recent release dating back to August 23rd, 2023. This limited information raises the question: What is driving this impressive rally? We will delve into the details below to shed light on the matter.

Cannabis Industry:

If you’ve been following our newsletter, you may have noticed our recent article spotlighting Flora Growth Corp. (NASDAQ: FLGC), along with larger players like Cronos Group Inc. (NASDAQ: CRON), and Canopy Growth Corporation (NASDAQ: CGC).

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

In case you haven’t had a chance to read it, you can find the article here, featuring a dedicated section on the broader trends shaping the cannabis industry.

For those seeking a quick summary, a significant development has emerged in the cannabis landscape. A high-ranking official at the Department of Health and Human Services (HHS) has proposed moving cannabis from Schedule I to Schedule III of the Controlled Substances Act. This shift marks a historic moment and comes after a comprehensive yearlong investigation requested by President Biden.

It’s worth noting the potential implications of this change for U.S.-based, plant-touching marijuana companies. Currently, these companies are restricted from trading on major exchanges like the NYSE or NASDAQ and are relegated to smaller markets such as the OTC, or smaller Canadian markets like the TSX, CSE, or NEO.

The CEO of Trulieve Cannabis Corp. (OTC: TCNNF), Kim Rivers delves into these implications in a podcast conversation with a Twitter user known as @stock_mj. She also recommends keeping a close eye on the AdvisorShares Pure US Cannabis ETF (MSOS) as the cannabis sector garners increasing attention from investors.

Weedmap’s Earnings:

To evaluate the potential of MAPS, it’s essential to examine their recent earnings and assess the fundamentals. Here’s a brief overview of the news release.

Revenue: Amounted to $50.9 million, representing a decline compared to the same period in the prior year when it reached $58.3 million.

Net Income: Recorded at $2.0 million for the second quarter of 2023, marking a significant decrease from the previous year’s figure of $19.8 million.

Adjusted EBITDA: Showed substantial improvement, totaling $10.2 million in the second quarter of 2023, as opposed to a negative figure of $(0.6) million in the same period of the prior year.

Cash: As of June 30, 2023, the company held $24.6 million in cash, noteworthy for being entirely debt-free.

WM Technology’s Executive Chair, Doug Francis, underscored the company’s dedication to reinforcing its financial position and delivering sustained growth.

Guidance for the third quarter of 2023:

Revenue: An estimated $47 million.

Non-GAAP Adjusted EBITDA: Approximately $4 million.

It’s important to note that these projections are subject to potential variations based on various factors and developments.

Furthermore, WM Technology announced the transition to Moss Adams LLP as its new independent registered public accounting firm, effective upon the filing of the Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, following the resignation of Baker Tilly US, LLP due to staffing constraints.

Although the company maintains a debt-free status, it’s crucial to recognize that there has been a substantial decline in both revenue and net income. Consequently, it is advisable to exercise caution when considering investment, as the current trajectory of their top-line figures does not exhibit a positive trend.

https://twitter.com/5teelersfan/status/1699102436672299134?s=20

Weedmap’s Strategic Partnership:

Furthermore, the company made another recent announcement regarding its strategic partnership with the producer of “The Freak Brothers,” a celebrated stoner comic series that has captivated audiences for over five decades.

The series follows the adventures of three stoner characters and their cat, who awaken from a 50-year slumber induced by a magical strain of weed in 1969, now navigating life in contemporary San Francisco.

Key highlights of this partnership include in-episode Weedmaps integrations in the upcoming second half of “Freak Brothers” season two, commencing on September 24th. Additionally, exclusive “Smoke & Screen” events will be held across the U.S., bringing together influential figures from both the cannabis and entertainment industries.

“The Freak Brothers” series, based on Gilbert Shelton’s cult classic comic, celebrates its 55th anniversary with a star-studded voice cast for Season 2, featuring Woody Harrelson, John Goodman, Pete Davidson, Tiffany Haddish, Adam Devine, Blake Anderson, Andrea Savage, La La Anthony, ScHoolboy Q, and a special guest appearance by Joe Sikora.

To watch Season 2 of “The Freak Brothers,” visit Tubitv.com, and for cannabis-related information, explore Weedmaps.com. For more on “The Freak Brothers,” visit the official website at www.thefreakbrothers.com.

We will update you on MAPS when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by NickyPe from Pixabay.com

Continue Reading

Emerging Markets

Cannabis Industry Surges: Flora Growth Corp. (NASDAQ: FLGC) Leads the Way with 77% Intraday Jump

Published

3 weeks ago

on

August 31, 2023

By

Flora Growth Corp. (NASDAQ: FLGC) experienced a remarkable intraday surge of over 77%. While the company has made significant announcements recently, today’s surge occurred without any specific filings or press releases to explain it. There seems to be something substantial driving this trading frenzy, a broader force impacting the entire asset class.

It’s worth noting that established industry leaders like Canopy Growth Corporation (NASDAQ: CGC) and Cronos Group Inc. (NASDAQ: CRON) have faced significant downtrends in past years. However, today’s market activity also lifted their stocks along with others. To understand this trend, let’s take a closer look at the larger market dynamics at play.

 

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

What Happened:

A top official at the Department of Health and Human Services (HHS) has recommended moving cannabis from Schedule I to Schedule III of the Controlled Substances Act, marking a historic shift. This move follows a comprehensive yearlong investigation requested by President Biden.

https://twitter.com/NotFinancialRep/status/1697189406665245149?s=20

In the short term, this won’t significantly impact the cannabis industry, as the Drug Enforcement Agency (DEA) needs to conduct its own review and the federal prohibition on marijuana remains. However, the HHS recommendation, if followed by the DEA, could happen within a year, possibly before the 2024 presidential election.

Long-term implications for the cannabis industry are uncertain, but a key immediate effect would be the elimination of Section 280e of the IRS tax code for cannabis businesses. This provision currently prevents them from claiming standard business deductions, a major financial burden.

While rescheduling won’t directly open up access to institutional banking, it may attract new capital sources due to reduced risk perception among investors. Smaller banks and lenders might become more willing to engage.

Eliminating 280e could also stimulate lending in an industry with high borrowing costs, as companies would have improved cash flow. This might lead to lower interest rates and greater access to operating and expansion capital.

Rescheduling could benefit publicly traded cannabis companies, potentially enticing more exchanges, like the Toronto Stock Exchange, to accept U.S.-based cannabis businesses. It could also encourage Congress to take further action, such as passing the SAFE Banking Act and broader reforms.

Overall, while the exact implications of rescheduling are uncertain, the HHS announcement signals progress toward a post-prohibition reality for the cannabis industry, which is a significant development.

https://twitter.com/S_Andreoni/status/1697289527180562880?s=20

Having set the stage with the broader cannabis industry context, let’s delve into Flora Growth’s recent developments and their implications for the company’s future. Is Flora Growth strategically positioned to leverage the potential easing of restrictions in the cannabis sector?

European Expansion:

Flora Growth just formed a partnership with TruHC Pharma GmbH, a leading medical cannabis expert based in Hamburg, Germany. TruHC holds key certifications for importing, distributing, and manufacturing medical cannabis and is awaiting an EU-GMP license for its cutting-edge cannabis laboratory.

Hendrik Knopp, a respected legal professional and entrepreneur, and his team from TruHC are joining Flora, bringing their extensive expertise in pioneering medical cannabis in Germany. This partnership is seen as very valuable, especially as Germany and the European Union move towards making medical cannabis more accessible to patients.

Clifford Starke, CEO of Flora, expressed excitement about the collaboration, recognizing the potential to contribute to the growth of the medical cannabis industry as regulations evolve. The partnership aims to capture a significant market share in Germany.

Hulk Hogan Partnership:

Flora Growth also just recently entered an exclusive worldwide partnership with WWE legend Hulk Hogan to launch a range of consumer products through Just Brands. These products will include CBD-infused items like pre-rolls, topicals, edibles, and more, which Flora will produce and sell globally. The partnership aims to capitalize on Hulk Hogan’s iconic status and Flora’s global distribution network. The initial agreement is for three years, with potential renewals, targeting $20 million in sales over the first 24 months. Flora will pay royalties and license fees for Hulk Hogan-branded products.

Conclusion:

In summary, the cannabis industry appears ready for a resurgence, buoyed by renewed investor optimism and shifting market dynamics. Our focus today was Flora Growth Corp. (NASDAQ: FLGC) but larger names like Canopy Growth Corporation (NASDAQ: CGC) and Cronos Group Inc. (NASDAQ: CRON) are among the many companies benefitting from this positive trend.

We will update you on FLGC when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by 7raysmarketing from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.